5' terminal nucleotide sequences of type C retroviruses: features common to noncoding sequences of eucaryotic messenger RNAs.

PubWeight™: 1.19‹?› | Rank: Top 10%

🔗 View Article (PMID 6248246)

Published in Cell on June 01, 1980

Authors

G G Lovinger, G Schochetman

Articles by these authors

DNA amplification for direct detection of HIV-1 in DNA of peripheral blood mononuclear cells. Science (1988) 13.46

Transmission of human immunodeficiency virus in a dental practice. Ann Intern Med (1992) 5.36

Independent introduction of two major HIV-1 genotypes into distinct high-risk populations in Thailand. Lancet (1993) 3.28

Molecular epidemiology of HIV transmission in a dental practice. Science (1992) 3.10

The emerging genetic diversity of HIV. The importance of global surveillance for diagnostics, research, and prevention. JAMA (1996) 2.85

Direct detection of HIV RNA expression in seropositive subjects. Lancet (1988) 2.75

Presence of infectious polyadenylated RNA in coronavirus avian bronchitis virus. Virology (1977) 2.19

Human chromosome 12 is required for elevated HIV-1 expression in human-hamster hybrid cells. Science (1989) 2.03

Use of UV irradiation to reduce false positivity in polymerase chain reaction. Biotechniques (1991) 1.93

The phylogenetic history of immunodeficiency viruses. Nature (1988) 1.89

A replication-deficient HIV-1 DNA used for quantitation of the polymerase chain reaction (PCR). Nucleic Acids Res (1990) 1.76

The evolving molecular epidemiology of HIV-1 envelope subtypes in injecting drug users in Bangkok, Thailand: implications for HIV vaccine trials. AIDS (1995) 1.69

Inhibition of DNA synthesis by hydroxyurea: structure-activity relationships. Cancer Res (1967) 1.60

Molecular characterization of human immunodeficiency virus from Zaire: nucleotide sequence analysis identifies conserved and variable domains in the envelope gene. Gene (1987) 1.55

Highly specific V3 peptide enzyme immunoassay for serotyping HIV-1 specimens from Thailand. AIDS (1993) 1.54

Seven human immunodeficiency virus (HIV) antigen-antibody combination assays: evaluation of HIV seroconversion sensitivity and subtype detection. J Clin Microbiol (2001) 1.45

Type D primate retroviruses: a review. Cancer Res (1978) 1.39

Duration of human immunodeficiency virus infection before detection of antibody. Lancet (1989) 1.35

Isolation of separate precursor polypeptides for the mouse mammary tumor virus glycoproteins and nonglycoproteins. Virology (1978) 1.35

Rapid and quantitative detection of enzymatically amplified HIV-1 DNA using chemiluminescent oligonucleotide probes. AIDS Res Hum Retroviruses (1990) 1.33

Identification of single and dual infections with distinct subtypes of human immunodeficiency virus type 1 by using restriction fragment length polymorphism analysis. Virus Genes (1996) 1.33

Studies on human immunodeficiency virus-induced cytopathic effects: use of human rhabdomyosarcoma (RD) cells. Arch Virol (1988) 1.33

Hydroxyurea-induced inhibition of deoxyribonucleotide synthesis: studies in intact cells. Cancer Res (1967) 1.32

Sensitivity of United States HIV antibody tests for detection of HIV-1 group O infections. Lancet (1994) 1.32

Antigenic variation and serotyping of HIV type 1 from four World Health Organization-sponsored HIV vaccine sites. WHO Network for HIV Isolation and Characterization. AIDS Res Hum Retroviruses (1994) 1.31

Comparison of antigen assay and reverse transcriptase assay for detecting human immunodeficiency virus in culture. J Clin Microbiol (1987) 1.29

HIV type 1 in Thailand, 1994-1995: persistence of two subtypes with low genetic diversity. AIDS Res Hum Retroviruses (1998) 1.24

Early HIV type 1 strains in Thailand were not responsible for the current epidemic. AIDS Res Hum Retroviruses (1994) 1.23

Independent polypeptide chain initiation sites for the synthesis of different classes of proteins for an RNA tumor virus: mouse mammary tumor virus. Virology (1976) 1.20

Genetic variability of HIV-1. AIDS (1996) 1.19

HIV-1 group O virus identified for the first time in the United States. Emerg Infect Dis (1996) 1.18

Topographical analysis of viral epitopes using monoclonal antibodies: mechanism of virus neutralization. Virology (1981) 1.14

Characterization of the messenger RNA released from L cell polyribosomes as a result of temperature shock. J Mol Biol (1972) 1.13

Wide distribution of two subtypes of HIV-1 in Thailand. AIDS Res Hum Retroviruses (1992) 1.12

Characterization of mouse mammary tumor viruses from primary tumor cell cultures.I. Immunologic and structural studies. J Natl Cancer Inst (1976) 1.11

Gene order of mouse mammary tumor virus precusor polyproteins and their interaction leading to the formation of a virus. Virology (1979) 1.11

Differential replication and pathogenic effects of HIV-1 and HIV-2 in Macaca nemestrina. AIDS (1994) 1.10

RNA subunit structure of Mason-Pfizer monkey virus. J Virol (1975) 1.09

Distribution of Mason-Pfizer virus-specific sequences in the DNA of primates. J Virol (1977) 1.09

Serotyping of HIV type 1 infections: definition, relationship to viral genetic subtypes, and assay evaluation. UNAIDS Network for HIV-1 Isolation and Characterization. AIDS Res Hum Retroviruses (1998) 1.09

Viral epitopes and monoclonal antibodies: isolation of blocking antibodies that inhibit virus neutralization. Science (1981) 1.07

Processing and amino acid sequence analysis of the mouse mammary tumor virus env gene product. J Virol (1982) 1.07

Analysis of lymphocytes, monocytes, and neutrophils from human immunodeficiency virus (HIV)-infected persons for HIV DNA. J Infect Dis (1990) 1.04

Epidemiologic and evolutionary relationships between Romanian and Brazilian HIV-subtype F strains. Emerg Infect Dis (1996) 1.04

Horizontal and vertical transmission of human immunodeficiency virus type 1 dual infections caused by viruses of subtypes B and C. J Infect Dis (1998) 1.03

Quantification of HIV-1 group M (subtypes A-G) and group O by the LCx HIV RNA quantitative assay. J Virol Methods (2000) 1.01

5'-terminal nucleotide sequences of the Rauscher leukemia virus and gibbon ape leukemia virus genomes exhibit a high degree of correspondence. J Virol (1979) 1.01

Oligomeric nature of transmembrane glycoproteins of HIV-2: procedures for their efficient dissociation and preparation of Western blots for diagnosis. AIDS (1991) 1.01

Mice with spontaneous mammary tumors develop type-specific neutralizing and cytotoxic antibodies against the mouse mammary tumor virus envelope protein gp52. J Virol (1979) 1.00

Unintegrated murine leukemia viral DNA in newly infected cells. Virology (1974) 1.00

Mason-Pfizer monkey virus: analysis and localization of virion proteins and glycoproteins. J Virol (1975) 1.00

TAR loop-dependent human immunodeficiency virus trans activation requires factors encoded on human chromosome 12. J Virol (1993) 1.00

Efficacies of US Food and Drug Administration-licensed HIV-1-screening enzyme immunoassays for detecting antibodies to HIV-2. AIDS (1990) 0.99

Lack of correlation between maternal antibodies to V3 loop peptides of gp120 and perinatal HIV-1 transmission. The NYC Perinatal HIV Transmission Collaborative Study. AIDS (1991) 0.99

Genetic analysis of human immunodeficiency virus in Abidjan, Ivory Coast reveals predominance of HIV type 1 subtype A and introduction of subtype G. AIDS Res Hum Retroviruses (1999) 0.99

Genetic diversity of human immunodeficiency virus type 1 strains in Kinshasa, Zaire. AIDS Res Hum Retroviruses (1993) 0.98

Monoclonal antibodies identify individual determinants on mouse mammary tumor virus glycoprotein gp52 with group, class, or type specificity. J Virol (1980) 0.98

Type-specific determinants on proteins of an endogenous C3H mouse mammary tumor virus (MMTV) distinguish this virus from highly oncogenic exogenous MMTVs. Virology (1981) 0.97

Testing for antibodies to human immunodeficiency virus type 2 in the United States. MMWR Recomm Rep (1992) 0.97

Establishment of a C3Hf mammary tumor cell line expressing endogenous mouse mammary tumor virus: antigenic and genetic relationships of this virus with highly oncogenic mouse mammary tumor viruses. J Virol (1979) 0.96

Surveillance for human immunodeficiency virus type 1 group O infections in the United States. Transfusion (1996) 0.95

Kinetics of murine type C virus-specific DNA synthesis newly infected cells. J Virol (1975) 0.93

Advances and problems in the diagnosis of human immunodeficiency virus infection in infants. Pediatr Infect Dis J (1991) 0.93

HIV-1 and HIV-2 infection associated with AIDS in Abidjan, Côte d'Ivoire. AIDS (1989) 0.92

Staphylococcal transfer ribonucleic acids. I. Isolation and purification of the isoaccepting glycine transfer ribonucleic acids from Staphylococcus epidermidis Texas 26. J Biol Chem (1974) 0.92

5'-terminal nucleotide noncoding sequences of retroviruses: relatedness of two old world primate type C viruses and avian spleen necrosis virus. J Virol (1981) 0.91

Messenger RNA: its origin and fate in mammalian cells. Basic Life Sci (1973) 0.90

V3 loops of HIV-1 specimens from pregnant women in Malawi uniformly lack a potential N-linked glycosylation site. AIDS Res Hum Retroviruses (1993) 0.89

Acute human immunodeficiency virus infection. Antigen detection and seroconversion in immunosuppressed patients. Transplantation (1989) 0.89

Generation of a mouse mammary tumor virus (MMTV) pseudotype of Kirsten sarcoma virus and restriction of MMTV gag expression in heterologous infected cells. Virology (1979) 0.88

Mouse mammary tumor virus and murine leukemia virus cell surface antigens on virus producer and nonproducer mammary epithelial tumor cells. Virology (1978) 0.88

The 1990 Florida dental investigation. The press and the science. Ann Intern Med (1994) 0.87

The mechanism of replication of phi X174 single-stranded DNA. VI. Requirements for ribonucleoside triphosphates and DNA polymerase 3. Can J Biochem (1973) 0.87

Common surface receptors on both mouse and rat cells distinguish different classes of mouse mammary tumor viruses. Virology (1981) 0.86

Dynamics of maternal IgG antibody decay and HIV-specific antibody synthesis in infants born to seropositive mothers. The NYC Perinatal HIV Transmission Study Group. AIDS Res Hum Retroviruses (1993) 0.86

Factors influencing HIV-1 banding patterns in miniaturized western blot testing of dried blood spot specimens. J Immunol Methods (1992) 0.86

HIV type 1 subtypes in Malaysia include B, C, and E. AIDS Res Hum Retroviruses (1996) 0.86

Comparative performances of an HTLV-I/II EIA and other serologic and PCR assays on samples from persons at risk for HTLV-II infection. Transfusion (2000) 0.86

The effect of cordycepin on cell transformation by RNA tumor viruses. Virology (1973) 0.85

Antigenic analysis of the major structural protein of the Mason-Pfizer monkey virus. J Immunol (1976) 0.85

Group O human immunodeficiency virus-1 infections. Infect Dis Clin North Am (1998) 0.85

Human chromosome-dependent and -independent pathways for HIV-2 trans-activation. AIDS Res Hum Retroviruses (1991) 0.84

Characterization of a retravirus isolated from squirrel monkeys. J Virol (1977) 0.83

HIV-1 patients may harbor viruses of different phylogenetic subtypes: implications for the evolution of the HIV/AIDS pandemic. Emerg Infect Dis (1996) 0.83

The nucleotides at the RNA-DNA joint formed by the DNA polymerase of Rauscher leukemia virus. Virology (1972) 0.83

C3H/HeN mammary tumor-bearing mice develop type-specific neutralizing antibodies and group-specific precipitating antibodies for the mouse mammary tumor virus. J Virol (1980) 0.82

Sialylatin of glycoproteins of murine mammary tumor virus, murine leukemia virus, and Mason-Pfizer monkey virus. J Virol (1976) 0.82

Naturally occurring sequence polymorphisms within HIV type 1 group O protease. AIDS Res Hum Retroviruses (2001) 0.82

Prevalence of human immunodeficiency virus type 1 DNA in hemophilic men and their sex partners. Hemophilia-AIDS Collaborative Study Group. J Infect Dis (1989) 0.81

Monoclonal and polyclonal antibody studies of VSV(hrMMTV) pseudotypes. Virology (1982) 0.81

Evaluation of testing algorithms following the use of combination HIV-1/HIV-2 EIA for screening purposes. AIDS Res Hum Retroviruses (1993) 0.80

Misidentification of HIV-2 proteins by western blots. Lancet (1991) 0.80

Nonradioactive, colorimetric microplate hybridization assay for detecting amplified human immunodeficiency virus DNA. Clin Chem (1993) 0.79

A highly heterogeneous HIV-1 epidemic in the Central African Republic. Emerg Infect Dis (1996) 0.79

Genetic variability of human immunodeficiency virus type 1 in rural northwest Tanzania. AIDS Res Hum Retroviruses (1996) 0.78

A human chromosome 12-associated 83-kilodalton cellular protein specifically binds to the loop region of human immunodeficiency virus type 1 trans-activation response element RNA. J Virol (1995) 0.78

Ribonucleoside diphosphate precursors for in vitro reovirus RNA synthesis. Nat New Biol (1972) 0.76